Kevin Kimberly Smith, MD | |
1550 S Pioneer Way Ste 100, Moses Lake, WA 98837-4637 | |
(509) 765-6525 | |
Not Available |
Full Name | Kevin Kimberly Smith |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 1550 S Pioneer Way Ste 100, Moses Lake, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790847952 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MD00023951 (Washington) | Primary |
208D00000X | General Practice | MD00023951 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kevin Kimberly Smith, MD 1550 S Pioneer Way Ste 100, Moses Lake, WA 98837-4637 Ph: (509) 765-6525 | Kevin Kimberly Smith, MD 1550 S Pioneer Way Ste 100, Moses Lake, WA 98837-4637 Ph: (509) 765-6525 |
News Archive
Research on how junior high school students' beliefs about intelligence affect their math grades found that those who believed that intelligence can be developed performed better than those who believed intelligence is fixed.
Prostate cancer doesn't kill in the prostate - it's the disease's metastasis to other tissues that can be fatal. A University of Colorado Cancer Center study published this week in the Journal of Biological Chemistry shows that prostate cancer cells containing the protein SPDEF continue to grow at the same pace as their SPDEF- cousins, but that these SPDEF+ cells are unable to survive at possible sites of metastasis.
Tinnitus, migraine, epilepsy, depression, schizophrenia, Alzheimer's: all these are examples of diseases with neurological causes, the treatment and study of which is more and more frequently being carried out by means of magnetic stimulation of the brain. However, the method's precise mechanisms of action have not, as yet, been fully understood.
GenoMed announced today that the US Patent Office has allowed claims and will be following up with an issued patent shortly on the Company's protocol to treat acute kidney failure with a drug rather than the dialysis machine.
› Verified 1 days ago